Although Beclin1 haploinsufficiency did not elicit any discernable effect on baseline or MI-evoked changes in echocardiographic indices (MI-induced rise in LV EDD failed to reach statistical significance in BECN +/− mice), it removed MSCs-induced beneficial effects against MI (Fig. 3 ).
← all excerpts
Beclin1 haploinsufficiency compromises mesenchymal stem cell-offered cardioprotection against myocardial infarction.
1
—
—